Kazachstania slooffiae Fungemia: A Case Report and Literature Review on an Emerging Opportunistic Pathogen in Humans - Takeaways - MDSpire

Kazachstania slooffiae Fungemia: A Case Report and Literature Review on an Emerging Opportunistic Pathogen in Humans

  • By

  • Sarah N Fortna

  • David M Aronoff

  • Andrew T Dysangco

  • April 4, 2025

  • 0 min

Share

  • 1

    Kazachstania slooffiae fungemia was identified in a 77-year-old immunocompromised male with significant gastrointestinal abnormalities.

  • 2

    This case represents the first documented instance of Kazachstania slooffiae as a bloodstream pathogen in humans.

  • 3

    Diagnosis of Kazachstania slooffiae infections relies on advanced techniques like MALDI-TOF mass spectrometry and DNA sequencing.

  • 4

    Antifungal treatments, including micafungin, have shown favorable outcomes in managing Kazachstania slooffiae infections.

  • 5

    Kazachstania slooffiae is emerging as an opportunistic pathogen, particularly in critically ill, immunocompromised patients.

Original Source(s)

Kazachstania slooffiae Fungemia: A Case Report and Literature Review on an Emerging Opportunistic Pathogen in Humans

  • by Sarah N Fortna, David M Aronoff, Andrew T Dysangco

  • April 4, 2025

Related Content

Severe cutaneous anthrax with systemic complications: a case report

Elevated plasma cholesterol improves sepsis outcome by promoting hepatic metabolic reprogramming

The Prognostic Value of Red Cell Distribution Width-to-Albumin Ratio for 28-Day Mortality in Sepsis Patients: A Multicenter Analysis Based on the eICU Collaborative Research Database